Literature DB >> 10431891

Assessment of dysequilibrium after acoustic neuroma removal.

S G Lynn1, C L Driscoll, S G Harner, C W Beatty, E J Atkinson.   

Abstract

OBJECTIVE: Published data evaluating the rate of dysequilibrium after acoustic neuroma removal are inconsistent. The purpose of this investigation was to determine the incidence and severity of dysequilibrium and quality of life in a group of patients after acoustic neuroma surgery. STUDY
DESIGN: The study design was a retrospective chart review and survey that included demographic and medical history questions, the Dizziness Handicap Inventory (DHI), the UCLA Dizziness Questionnaire (UCLA-DQ), and the Health Status Questionnaire (HSQ).
SETTING: The study was conducted in a multispecialty tertiary care clinic. PATIENTS: Two hundred thirty-seven subjects who underwent initial surgical removal of an acoustic neuroma between January 1990 and June 1997 were studied. MAIN OUTCOME MEASURES: Correlation of dysequilibrium with age, gender, and tumor size was measured. Survey analysis including DHI, UCLA-DQ, and HSQ scores.
RESULTS: Sixty-five percent of patients reported persistent dysequilibrium after surgery. A majority of those with dysequilibrium had DHI, UCLA-DQ, and HSQ scores that suggested minimal impact on the quality of life. The HSQ scores were statistically significantly poorer for the patients with dysequilibrium than for those without dysequilibrium.
CONCLUSIONS: Sixty-five percent of patients reported dysequilibrium after acoustic neuroma removal. The quality-of-life impact was mild.

Entities:  

Mesh:

Year:  1999        PMID: 10431891

Source DB:  PubMed          Journal:  Am J Otol        ISSN: 0192-9763


  9 in total

1.  Head tilt is pronounced after an ipsilateral head roll in patients with vestibular schwannoma.

Authors:  Topi Jutila; Heikki Aalto; Timo P Hirvonen
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-11-29       Impact factor: 2.503

2.  Exercise with visual feedback improves postural stability after vestibular schwannoma surgery.

Authors:  Ondrej Cakrt; Martin Chovanec; Tomás Funda; Petra Kalitová; Jan Betka; Eduard Zverina; Pavel Kolár; Jaroslav Jerábek
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-03-30       Impact factor: 2.503

3.  [Acoustic neuroma (vestibular schwannoma) therapy from an oto-rhino-laryngological perspective].

Authors:  K Schwager
Journal:  HNO       Date:  2011-01       Impact factor: 1.284

Review 4.  Management of vestibular schwannoma: focus on vertigo.

Authors:  Manisha Dayal; Angelica Perez-Andujar; Cynthia Chuang; Andrew T Parsa; Igor J Barani
Journal:  CNS Oncol       Date:  2013-01

5.  Vestibular function and quality of life in vestibular schwannoma: does size matter?

Authors:  Judith Nastjenka Wagner; Miriam Glaser; Berndt Wowra; Alexander Muacevic; Roland Goldbrunner; Christian Cnyrim; Jörg-Christian Tonn; Michael Strupp
Journal:  Front Neurol       Date:  2011-08-30       Impact factor: 4.003

6.  Complications of microsurgery of vestibular schwannoma.

Authors:  Jan Betka; Eduard Zvěřina; Zuzana Balogová; Oliver Profant; Jiří Skřivan; Josef Kraus; Jiří Lisý; Josef Syka; Martin Chovanec
Journal:  Biomed Res Int       Date:  2014-05-28       Impact factor: 3.411

7.  Vestibulo-Ocular Reflex Stabilization after Vestibular Schwannoma Surgery: A Story Told by Saccades.

Authors:  Angel Batuecas-Caletrio; Jorge Rey-Martinez; Gabriel Trinidad-Ruiz; Eusebi Matiño-Soler; Santiago Santa Cruz-Ruiz; Angel Muñoz-Herrera; Nicolas Perez-Fernandez
Journal:  Front Neurol       Date:  2017-01-25       Impact factor: 4.003

8.  Different Visual Weighting due to Fast or Slow Vestibular Deafferentation: Before and after Schwannoma Surgery.

Authors:  Fredrik Tjernström; Per-Anders Fransson; Babar Kahlon; Mikael Karlberg; Sven Lindberg; Peter Siesjö; Måns Magnusson
Journal:  Neural Plast       Date:  2019-02-18       Impact factor: 3.599

9.  Asymmetry of balance responses to monaural galvanic vestibular stimulation in subjects with vestibular schwannoma.

Authors:  Miriam S Welgampola; Elijane Ramsay; Michael J Gleeson; Brian L Day
Journal:  Clin Neurophysiol       Date:  2013-05-01       Impact factor: 3.708

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.